The US FDA has expanded the approval of Regeneron Pharmaceuticals' fully human monoclonal antibody, Evkeeza (evinacumab-dgnb) ...
Amgen has revealed a significant investment plan, earmarking $650m to enhance its manufacturing operations in the US.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback